INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "METHODS OF TREATING CANCER WITH A COMBINATION OF A PD1 INHIBITOR AND A TARGETED IMMUNOCYTOKINE"

GENEVA, April 21 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2024/050305) for "METHODS OF TREATING CANCER WITH A COMBINATION OF A PD1 INHIBITOR AND A TARGETED IMMUNOCYTOKINE" on Oct 08, 2024. With publication no. WO/2025/080538, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): WU, Jiaxi (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mill River RoadTarrytown, New York 10591), BHAVSAR, Ramandeep (c/o Regeneron Pharmaceuticals, Inc.777 Old Saw Mi...